Found: 10
Select item for more details and to access through your institution.
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extraneural metastases of medulloblastoma: Desmoplastic variants may have prolonged survival.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 4, p. 611, doi. 10.1002/pbc.25354
- By:
- Publication type:
- Article
Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 4, p. 591, doi. 10.1002/pbc.22347
- By:
- Publication type:
- Article
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 49, n. 3, p. 261, doi. 10.1002/pbc.21045
- By:
- Publication type:
- Article
Patterns of relapse for children with localized intracranial ependymoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 138, n. 2, p. 435, doi. 10.1007/s11060-018-2815-7
- By:
- Publication type:
- Article
Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 1, p. 95, doi. 10.1007/s11060-017-2627-1
- By:
- Publication type:
- Article
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. 1763, doi. 10.1093/neuonc/noac035
- By:
- Publication type:
- Article
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178593
- By:
- Publication type:
- Article